- Home
- BCML vs IPHA Comparison
BCML vs IPHA Comparison
Compare BCML & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- IPHA
- Stock Information
- Founded
- BCML 2004
- IPHA 1999
- Country
- BCML United States
- IPHA France
- Employees
- BCML N/A
- IPHA N/A
- Industry
- BCML Major Banks
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- BCML Finance
- IPHA Health Care
- Exchange
- BCML Nasdaq
- IPHA Nasdaq
- Market Cap
- BCML 261.8M
- IPHA 175.5M
- IPO Year
- BCML N/A
- IPHA 2019
- Fundamental
- Price
- BCML $24.50
- IPHA $2.00
- Analyst Decision
- BCML
- IPHA Strong Buy
- Analyst Count
- BCML 0
- IPHA 1
- Target Price
- BCML N/A
- IPHA $11.50
- AVG Volume (30 Days)
- BCML 16.2K
- IPHA 9.4K
- Earning Date
- BCML 10-25-2024
- IPHA 09-12-2024
- Dividend Yield
- BCML 1.66%
- IPHA N/A
- EPS Growth
- BCML N/A
- IPHA N/A
- EPS
- BCML 2.12
- IPHA N/A
- Revenue
- BCML $97,490,000.00
- IPHA $36,202,722.00
- Revenue This Year
- BCML N/A
- IPHA N/A
- Revenue Next Year
- BCML $3.40
- IPHA $102.87
- P/E Ratio
- BCML $11.40
- IPHA N/A
- Revenue Growth
- BCML N/A
- IPHA N/A
- 52 Week Low
- BCML $18.54
- IPHA $1.81
- 52 Week High
- BCML $25.04
- IPHA $3.15
- Technical
- Relative Strength Index (RSI)
- BCML 63.83
- IPHA 41.71
- Support Level
- BCML $23.25
- IPHA $1.94
- Resistance Level
- BCML $24.73
- IPHA $2.10
- Average True Range (ATR)
- BCML 0.42
- IPHA 0.08
- MACD
- BCML 0.08
- IPHA -0.01
- Stochastic Oscillator
- BCML 85.80
- IPHA 16.00
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.